Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Lonafarnib

EU orphan designation number: EU/3/18/2118   
Active ingredient: Lonafarnib
Indication: Treatment of Hutchinson-Gilford progeria syndrome
Sponsor: Eiger Biopharmaceuticals Europe Limited
30 Upper High Street, Thame, Oxon, OX9 3EZ, United Kingdom

  

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/12/2018 Orphan designation EMA/OD/159/18 (2018)9033 of 14/12/2018